These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4901568)

  • 1. Panel discussion: Proposed changes in the USP--microbiological aspects. 3. Proposed microbial limit tests.
    Vera HD
    Bull Parenter Drug Assoc; 1969; 23(6):257-60. PubMed ID: 4901568
    [No Abstract]   [Full Text] [Related]  

  • 2. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test.
    Clapp FL
    Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566
    [No Abstract]   [Full Text] [Related]  

  • 3. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panel discussion: Proposed changes in the USP--Microbiological aspects. II. Biological indicators.
    Artandi C
    Bull Parenter Drug Assoc; 1969; 23(6):254-7. PubMed ID: 4901567
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of low-level microbial contamination of drug preparations.
    Hess H; Knüsel F; Mullen K
    Pharm Acta Helv; 1969 Mar; 44(3):174-91. PubMed ID: 5790044
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent aspects of the microbiological contamination of pharmaceutical products and their microbiological specification (author's transl)].
    Kurata H; Ishizeki C; Udagawa S
    Eisei Shikenjo Hokoku; 1978; (96):1-26. PubMed ID: 373832
    [No Abstract]   [Full Text] [Related]  

  • 7. Activities of the USP Microbiology Subcommittee of Revision during the 1995-2000 revision cycle.
    Sutton SV; Knapp JE; Dabbah R
    PDA J Pharm Sci Technol; 2001; 55(1):33-48. PubMed ID: 11212419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological requirements for non-compulsory sterile drugs].
    Aureli P; Pasolini B
    Boll Chim Farm; 1985 Jun; 124(6):229-43. PubMed ID: 4063090
    [No Abstract]   [Full Text] [Related]  

  • 9. PDA particulate matter panel discussion--an industry perspective.
    Hammer HF
    J Parenter Sci Technol; 1984; 38(5):170-2. PubMed ID: 6512655
    [No Abstract]   [Full Text] [Related]  

  • 10. [Microbiological purity of pharmaceutical forms non-necessarily sterile].
    J Pharm Belg; 1972; 27(6):670-82. PubMed ID: 4665014
    [No Abstract]   [Full Text] [Related]  

  • 11. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
    Raiman HL
    Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessment of microbial contamination of several drugs].
    Strelkov VN; Borodina TM
    Gig Sanit; 1991 Apr; (4):48-9. PubMed ID: 1885048
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of bacteria in water for pharmaceutical use.
    Martino TK; Hernández JM; Beldarraín T; Melo L
    Rev Latinoam Microbiol; 1998; 40(3-4):142-50. PubMed ID: 10932743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological tests on oral pediatric medicines--requirements for an improved pharmacopoeia monograph.
    Long PF; Han J; Tuleu C; Wong IC
    Ann Pharmacother; 2006 Jan; 40(1):158-9. PubMed ID: 16368921
    [No Abstract]   [Full Text] [Related]  

  • 15. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Validation of demineralized water plants through total microbial count and definition of a microbiological standard].
    Anastasio P; Burinato C; Carazzone M; Ferioli S; Genova R; Malesani L; Molinari ML; Veronese M
    Boll Chim Farm; 1985 Jun; 124(6):259-70. PubMed ID: 4063093
    [No Abstract]   [Full Text] [Related]  

  • 17. Panel discussion: international drug regulations and their practical application. I. Swedish experience of drug regulations and their applications.
    Liljestrand A
    Bull Parenter Drug Assoc; 1974; 28(4):153-60. PubMed ID: 4853527
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of methods used to determine motility of strains of Gram-negative bacteria isolated from aqueous pharmaceutical preparations.
    Lowis MJ
    Lab Pract; 1969 Sep; 18(9):929-32. PubMed ID: 4900234
    [No Abstract]   [Full Text] [Related]  

  • 19. [RESULTS OF TESTING LIQUID PHARMACEUTICAL PREPARATIONS FROM PHARMACIES FOR MICROBIOLOGICAL CONTAMINATION].
    MEYER H
    Pharm Prax; 1964; 68():93-5. PubMed ID: 14240174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microbiological investigation of officinal galenical preparations].
    Pirisino G; Piu L; Ginanneschi R
    Boll Chim Farm; 1985 Oct; 124(10):432-8. PubMed ID: 4084398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.